Cosolvent effects on the drug release and depot swelling in injectable in situ depot-forming systems

Journal of Pharmaceutical Sciences

Volumn 101, Issue 5, 2012, Pages 1783-1793

  Liu, Hui ^a   Venkatraman, Subbu S ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Biodegradable polymers; Controlled release; Cosolvent; Depot forming; Diffusion; Drug transport; Polymeric drug delivery system; Swelling

Indexed keywords

1 METHYL 2 PYRROLIDINONE; DIMETHYL SULFOXIDE; TRIACETIN; 2 PYRROLIDONE DERIVATIVE; N-METHYLPYRROLIDONE; SOLVENT;

ARTICLE; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; HYDROPHILICITY; HYDROPHOBICITY; PH; CHEMISTRY; DELAYED RELEASE FORMULATION; KINETICS;

DELAYED-ACTION PREPARATIONS; DIMETHYL SULFOXIDE; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; KINETICS; PYRROLIDINONES; SOLVENTS; TRIACETIN;

EID: 84862678080     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.23065     Document Type: Article

References (30)

1. Hatefi A, Amsden B. 2002. Biodegradable injectable in situ forming drug delivery systems. J Control Release 80:9-28.
2. Packhaeuser CB, Schnieders J, Oster CG, Kissel T. 2004. In situ forming parenteral drug delivery systems: An overview. Eur J Pharm Biopharm 58(2):445-455.
3. Bezwada RS. 1995. Preparation of liquid copolymers of e-caprolactone and lactide. Patent US5442033.
4. Schwach-Abdellaoui K, Moreau M, Schneider M, Boisramc B, Gurny R. 2002. Controlled delivery of metoclopramide using an injectable semi-solid poly(ortho ester) for veterinary application. Int J Pharm 248:31-37.
5. Sawhney AS, Pathak CP, Hubbell JA. 1993. Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly(alphahydroxy acid) diacrylate macromers. Macromolecules 26:581-587.
6. Krauland AH, Leitner VM, Bernkop-Schnuerch A. 2003. Improvement in the in situ gelling properties of deacetylated gellan gum by the immobilization of thiol groups. J Pharm Sci 92:1234-1241.
7. Bochot A, Fattal E, Gulik A, Couarraze G, Couvreur P. 1998. Liposomes dispersed within a thermosensitive gel: A new dosage form for ocular delivery of oligonucleotides. Pharm Res 15:1364-1369.
8. Jeong B, Choi YK, Bae YH, Zentner G, Kim SW. 1999. New biodegradable polymers for injectable drug delivery systems. J Control Release 62:109-114.
9. Lambert WJ, Peck KD. 1995. Development of an in situ forming biodegradable poly-lactide-co-glycolide system for the controlled release of proteins. J Control Release 33:189-195.
10. Brodbeck KJ, Pushpala S, McHugh AJ. 1999. Sustained release of human growth hormone from PLGA solution depots. Pharm Res 16:1825-1829.
11. Ravivarapu HB, Moyer KL, Dunn RL. 2000. Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide. Int J Pharm 194:181-191.
12. Dunn RL, English JP, Cowsar DR, Vanderbilt DP. 1990. Biodegradable in situ forming implants and methods of producing the same. Patent US4938763.
13. Dunn RL, Tipton AJ, Southard GL, Rogers JA. 1997. Biodegradable polymer composition. Patent US5599552.
14. Dunn RL, Garrett JS, Ravivarapu H, Chandrashekar BL. 2003. Polymeric delivery formulations of leuprolide with improved efficacy. Patent US6565874.
15. Ravivarapu HB, Moyer KL, Dunn RL. 2000. Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate. J Pharm Sci 89(6):732-741.
16. Chandrashshekar BL, Zhou MX, Jarr EM, Dunn RL. 2000. Controlled release liquid delivery compositions with low intial drug burst. Patent US6143314.
17. Brodbeck KJ, Pushpala SJ, Prestrelski SJ. 2006. Implantable gel compositions and method of manufacture. Patent Application US2006/0233841.
18. Dunn RL. 2006. Emulsions for in situ delivery systems. Patent US7128927.
19. Brodbeck KJ, Gaynor-Duarte AT, Shen TT-I. 2004. Gel composition and methods. Patent US6673767.
20. Chern RT, Zingerman JR. 2004. Liquid polymeric compositions for controlled release of bioactive substances. Patent US6733767.
21. Prabhu S, Tran LP, Betageri GV. 2005. Effect of co-solvents on the controlled release of calcitonin polypeptide from in situ biodegradable polymer implants. Drug Deliv 12(6):393-398.
22. Brodbeck KJ, DesNoyer JR, McHugh AJ. 1999. Phase inversion dynamics of PLGA solutions related to drug delivery Part II. The role of solution thermodynamics and bath-side mass transfer. J Control Release 62:333-344.
23. Graham PD, Brodbeck KJ, McHugh AJ. 1999. Phase inversion dynamics of PLGA solutions related to drug delivery. J Control Release 58:233-245.
24. Singh S, Singh J. 2004. Controlled release of a model protein lysozyme from phase sensitive smart polymer systems. Int J Pharm 271(1-2):189-196.
25. Wang L, Kleiner L, Venkatraman S. 2003. Structure formation in injectable poly(lactide-co-glycolide) depots. J Control Release 90:345-354.
26. Wang L, Venkatraman S, Kleiner L. 2004. Drug release from injectable depots: Two different in vitro mechanisms. J Control Release 99:207-216.
27. Wang L, Venkatraman S, Gan LH, Kleiner L. 2005. Structure formation in injectable poly(lactide-co-glycolide) depots. II. Nature of the gel. J Biomed Mater Res, Part B 72B:215-222.
28. Kranz H, Brazeau GA, Napaporn J, Martin RL, Millard W, Bodmeier R. 2001. Myotoxicity studies of injectable biodegradable in situ forming drug delivery systems. Int J Pharm 212:11-18.
29. Liu H, Venkatraman SS. 2012. Effect of polymer type on the dynamics of phase inversion and drug release in injectable in situ gelling systems. J Biomater Sci Polym Ed 23:251-266.
30. Limpanuparb T, Punyain K, Tantirungrotechai Y. 2010. A DFT investigation of methanolysis and hydrolysis of triacetin. J Mol Struct: Theochem 955(1-3):23-32.